CN103269720A - 生长激素缀合物 - Google Patents

生长激素缀合物 Download PDF

Info

Publication number
CN103269720A
CN103269720A CN2011800458584A CN201180045858A CN103269720A CN 103269720 A CN103269720 A CN 103269720A CN 2011800458584 A CN2011800458584 A CN 2011800458584A CN 201180045858 A CN201180045858 A CN 201180045858A CN 103269720 A CN103269720 A CN 103269720A
Authority
CN
China
Prior art keywords
growth hormone
conjugate
compound
hgh
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN2011800458584A
Other languages
English (en)
Chinese (zh)
Inventor
H.S.安德森
K.马德森
H.德姆思
C.B.席奥特
L.诺斯科夫-劳里森
P.蒂格森
C.贝伦斯
M.古尔布兰特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk Health Care AG
Original Assignee
Novo Nordisk Health Care AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk Health Care AG filed Critical Novo Nordisk Health Care AG
Publication of CN103269720A publication Critical patent/CN103269720A/zh
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/554—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being a steroid plant sterol, glycyrrhetic acid, enoxolone or bile acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
CN2011800458584A 2010-07-22 2011-07-15 生长激素缀合物 Withdrawn CN103269720A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP10170439.3 2010-07-22
EP10170439 2010-07-22
US36770410P 2010-07-26 2010-07-26
US61/367704 2010-07-26
PCT/EP2011/062152 WO2012010516A1 (en) 2010-07-22 2011-07-15 Growth hormone conjugates

Publications (1)

Publication Number Publication Date
CN103269720A true CN103269720A (zh) 2013-08-28

Family

ID=43016576

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011800458584A Withdrawn CN103269720A (zh) 2010-07-22 2011-07-15 生长激素缀合物

Country Status (5)

Country Link
US (1) US20130143815A1 (enExample)
EP (1) EP2595661A1 (enExample)
JP (1) JP2013533264A (enExample)
CN (1) CN103269720A (enExample)
WO (1) WO2012010516A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109069569A (zh) * 2015-12-02 2018-12-21 韩美药品株式会社 使用脂肪酸衍生物的蛋白缀合物及其制备方法

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103509102B (zh) * 2012-06-15 2015-07-22 郭怀祖 野生型人生长激素突变体
WO2015036553A1 (en) 2013-09-16 2015-03-19 Novo Nordisk Health Care Ag Thiol functionalized polymers
ES2869309T3 (es) 2013-12-13 2021-10-25 Novo Nordisk Healthcare Ag Método para la conjugación de proteínas con tioéter
MA43348A (fr) 2015-10-01 2018-08-08 Novo Nordisk As Conjugués de protéines
AU2018309090B2 (en) 2017-08-04 2023-03-30 Amgen Inc. Method of conjugation of cys-mAbs
US20240067674A1 (en) * 2020-12-28 2024-02-29 Chugai Seiyaku Kabushiki Kaisha Method for loading amino acid on resin for solid-phase synthesis

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996012505A1 (de) * 1994-10-21 1996-05-02 Basf Aktiengesellschaft Konjugate aus einem poly- oder oligopeptid und einer niedermolekularen lipophilen verbindung
CN1269805A (zh) * 1997-07-14 2000-10-11 博尔德生物技术公司 生长激素和相关蛋白的衍生物
WO2001009163A2 (en) * 1999-07-30 2001-02-08 The University Court Of The University Of Glasgow Improvement of peptide transport by conjugation with bile acids

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
JPH0665280B2 (ja) 1987-03-04 1994-08-24 味の素株式会社 タンパクゲル化剤及びそれを用いるタンパクのゲル化方法
CA2345497A1 (en) 1988-10-28 1990-04-28 Genentech, Inc. Growth hormone variants and method for forming growth hormone variants
US5534617A (en) 1988-10-28 1996-07-09 Genentech, Inc. Human growth hormone variants having greater affinity for human growth hormone receptor at site 1
US5951972A (en) 1990-05-04 1999-09-14 American Cyanamid Company Stabilization of somatotropins and other proteins by modification of cysteine residues
WO1992009690A2 (en) 1990-12-03 1992-06-11 Genentech, Inc. Enrichment method for variant proteins with altered binding properties
IT1251895B (it) 1991-09-27 1995-05-26 Eniricerche Spa Mutanti dell'ormone della crescita umano e loro impiego
DE69635026T2 (de) 1995-09-21 2006-05-24 Genentech Inc., San Francisco Varianten des menschlichen wachstumshormons
US6136536A (en) 1997-10-29 2000-10-24 Genetics Institute, Inc. Rapid generation of stable mammalian cell lines producing high levels of recombinant proteins
US6656922B2 (en) * 1998-05-28 2003-12-02 Mediplex Corporation, Korea Oral delivery of macromolecules
US6358705B1 (en) 1998-07-16 2002-03-19 Novo Nordisk A/S Method of making proteins in transformed yeast cells
WO2002055532A2 (en) 2001-01-11 2002-07-18 Maxygen Aps Variant growth hormone molecules conjugated with macromolecular compounds
WO2002103024A2 (en) * 2001-06-14 2002-12-27 The Scripps Research Institute Stabilized proteins with engineered disulfide bonds
WO2004022593A2 (en) 2002-09-09 2004-03-18 Nautilus Biotech Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
ES2642214T3 (es) 2004-01-21 2017-11-15 Novo Nordisk Health Care Ag Conjugación de péptidos mediante transglutaminasa
US7998930B2 (en) 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
AT502353B1 (de) 2006-06-29 2007-07-15 Avl List Gmbh Verfahren und vorrichtung zur konditionierung eines o2-hältigen gases
US9873667B2 (en) 2006-07-27 2018-01-23 Emisphere Technologies Inc. Arylsulfanyl compounds and compositions for delivering active agents
US20080095837A1 (en) 2006-08-31 2008-04-24 Emisphere Technologies, Inc. Human growth hormone formulations
US8323688B2 (en) 2006-08-31 2012-12-04 Novartis Ag Pharmaceutical compositions comprising hGH for oral delivery
JP5390404B2 (ja) 2007-02-16 2014-01-15 エミスフェアー・テクノロジーズ・インク 活性薬剤を送達するための環状部分を有する化合物及び組成物
GB0716328D0 (en) 2007-08-21 2007-10-03 Univ Bath Detection and functionalisation of S-nitrosylated polypeptides
MX2011000847A (es) * 2008-08-06 2011-02-25 Novo Nordisk Healthcare Ag Proteinas conjugadas con eficacia prolongada in vivo.
JP5816097B2 (ja) * 2009-01-22 2015-11-18 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー 安定な成長ホルモン化合物
AU2011208620B2 (en) * 2010-01-22 2015-04-16 Novo Nordisk Health Care Ag Stable growth hormone compounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996012505A1 (de) * 1994-10-21 1996-05-02 Basf Aktiengesellschaft Konjugate aus einem poly- oder oligopeptid und einer niedermolekularen lipophilen verbindung
CN1269805A (zh) * 1997-07-14 2000-10-11 博尔德生物技术公司 生长激素和相关蛋白的衍生物
WO2001009163A2 (en) * 1999-07-30 2001-02-08 The University Court Of The University Of Glasgow Improvement of peptide transport by conjugation with bile acids

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PASCAL PECHER ET AL.: "The effect of additional disulfide bonds on the stability and folding of ribonuclease A", 《BIOPHYSICAL CHEMISTRY》, vol. 141, 30 December 2008 (2008-12-30), pages 27 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109069569A (zh) * 2015-12-02 2018-12-21 韩美药品株式会社 使用脂肪酸衍生物的蛋白缀合物及其制备方法
CN109069569B (zh) * 2015-12-02 2023-02-14 韩美药品株式会社 使用脂肪酸衍生物的蛋白缀合物及其制备方法

Also Published As

Publication number Publication date
EP2595661A1 (en) 2013-05-29
JP2013533264A (ja) 2013-08-22
US20130143815A1 (en) 2013-06-06
WO2012010516A1 (en) 2012-01-26

Similar Documents

Publication Publication Date Title
CN102834109B (zh) 稳定的生长激素化合物
US9211342B2 (en) Stable growth hormone compounds resistant to proteolytic degradation
CN103269720A (zh) 生长激素缀合物
AU2014350197A1 (en) Selective PYY compounds and uses thereof
JP2008543297A (ja) トランスグルタミナーゼを介した成長ホルモンのコンジュゲート
BRPI0713963A2 (pt) conjugados de proteìna e métodos para sua preparação
TWI504405B (zh) 穩定的生長激素化合物
JP5744844B2 (ja) 副甲状腺ホルモン（ｐｔｈ）受容体アゴニストとしての短鎖ペプチド
WO2022265109A1 (en) Ghr-binding pending peptide and composition comprising same
JP2008545644A (ja) 新規ポリ（エチレングリコール）誘導体とタンパク質へのそのカップリング方法
CN101365492A (zh) 转谷氨酰胺酶介导的生长激素的结合

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C04 Withdrawal of patent application after publication (patent law 2001)
WW01 Invention patent application withdrawn after publication

Application publication date: 20130828